ARMISTICE CAPITAL, LLC - Q2 2021 holdings

$5.59 Billion is the total value of ARMISTICE CAPITAL, LLC's 116 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 111.4% .

 Value Shares↓ Weighting
NewSPDR S&P 500 ETF TRput$1,155,762,00027,000
+100.0%
20.69%
NewISHARES TRput$619,299,00027,000
+100.0%
11.09%
CERC BuyCERECOR INC$127,857,000
+29.7%
39,100,000
+19.8%
2.29%
+1.1%
BIIB BuyBIOGEN INC$127,427,000
+58.2%
368,000
+27.8%
2.28%
+23.3%
VRTX BuyVERTEX PHARMACEUTICALS INC$120,978,000
+43.6%
600,000
+53.1%
2.17%
+12.0%
BMY BuyBRISTOL-MYERS SQUIBB CO$112,124,000
+18.4%
1,678,000
+11.9%
2.01%
-7.7%
MRTX BuyMIRATI THERAPEUTICS INC$106,610,000
+16.1%
660,000
+23.1%
1.91%
-9.5%
ALKS BuyALKERMES PLC$95,628,000
+45.3%
3,900,000
+10.7%
1.71%
+13.3%
PTCT BuyPTC THERAPEUTICS INC$88,429,000
+33.8%
2,092,000
+49.9%
1.58%
+4.3%
ENTA BuyENANTA PHARMACEUTICALS INC$88,020,000
+8.3%
2,000,000
+21.4%
1.58%
-15.5%
IOVA NewIOVANCE BIOTHERAPEUTICS INC$87,739,0003,372,000
+100.0%
1.57%
TVTX BuyTRAVERE THERAPEUTICS INC$83,863,000
+42.6%
5,748,000
+144.0%
1.50%
+11.1%
BURL NewBURLINGTON STORES INC$82,578,000256,462
+100.0%
1.48%
ZYME BuyZYMEWORKS INC$69,380,000
+33.1%
2,000,000
+21.2%
1.24%
+3.8%
CPB BuyCAMPBELL SOUP CO$59,815,000
+28.8%
1,312,000
+42.0%
1.07%
+0.5%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$57,667,000
+40.9%
592,000
+69.1%
1.03%
+9.8%
LULU BuyLULULEMON ATHLETICA INC$56,933,000
+456.2%
155,994
+367.4%
1.02%
+333.6%
UBER BuyUBER TECHNOLOGIES INC$54,731,000
+178.9%
1,092,000
+203.3%
0.98%
+117.3%
ENR BuyENERGIZER HLDGS INC NEW$54,670,000
+9.9%
1,272,000
+21.4%
0.98%
-14.3%
ARGX BuyARGENX SEsponsored adr$53,591,000
+29.7%
178,000
+18.7%
0.96%
+1.2%
CLX BuyCLOROX CO DEL$50,015,000
+3.7%
278,000
+11.2%
0.90%
-19.2%
TH NewTARGET HOSPITALITY CORP$46,348,000191,727
+100.0%
0.83%
HOLX NewHOLOGIC INC$42,167,000632,000
+100.0%
0.76%
HAE NewHAEMONETICS CORP MASS$41,583,000624,000
+100.0%
0.74%
SPPI BuySPECTRUM PHARMACEUTICALS INC$41,430,000
+18.8%
11,048,000
+3.3%
0.74%
-7.4%
WSM NewWILLIAMS SONOMA INC$41,059,000257,180
+100.0%
0.74%
VIAC BuyVIACOMCBS INCcl b$40,499,000
+43.9%
896,000
+43.6%
0.72%
+12.2%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$40,367,000
+15.6%
178,000
+15.6%
0.72%
-9.9%
ASO NewACADEMY SPORTS & OUTDOORS IN$38,160,000925,326
+100.0%
0.68%
TMO BuyTHERMO FISHER SCIENTIFIC INC$37,836,000
+42.9%
75,000
+29.3%
0.68%
+11.3%
ROST NewROSS STORES INC$36,197,000291,912
+100.0%
0.65%
ORLY NewOREILLY AUTOMOTIVE INC$34,700,00061,285
+100.0%
0.62%
TWNK BuyHOSTESS BRANDS INCcl a$33,869,000
+84.8%
2,092,000
+63.7%
0.61%
+43.9%
LW BuyLAMB WESTON HLDGS INC$32,264,000
+49.8%
400,000
+43.9%
0.58%
+16.8%
FL NewFOOT LOCKER INC$31,135,000505,187
+100.0%
0.56%
FB NewFACEBOOK INCcl a$29,208,00084,000
+100.0%
0.52%
PROG BuyPROGENITY INC$27,122,000
+117.3%
7,597,166
+189.7%
0.48%
+69.0%
NSTG NewNANOSTRING TECHNOLOGIES INC$26,953,000416,000
+100.0%
0.48%
SBUX NewSTARBUCKS CORP$26,834,000240,000
+100.0%
0.48%
KOF BuyCOCA-COLA FEMSA SAB DE CVsponsord adr rep$26,041,000
+29.3%
492,000
+12.8%
0.47%
+0.9%
CRSP BuyCRISPR THERAPEUTICS AGnamen akt$25,579,000
+34.6%
158,000
+1.3%
0.46%
+5.0%
TTWO NewTAKE-TWO INTERACTIVE SOFTWAR$24,075,000136,000
+100.0%
0.43%
MA NewMASTERCARD INCORPORATEDcl a$23,366,00064,000
+100.0%
0.42%
URBN NewURBAN OUTFITTERS INC$23,245,000563,936
+100.0%
0.42%
AHCO NewADAPTHEALTH CORP$20,174,000736,000
+100.0%
0.36%
KMB NewKIMBERLY-CLARK CORP$19,800,000148,000
+100.0%
0.35%
KDNY NewCHINOOK THERAPEUTICS INC$17,452,0001,236,000
+100.0%
0.31%
DCPH NewDECIPHERA PHARMACEUTICALS IN$17,280,000472,000
+100.0%
0.31%
WYNN BuyWYNN RESORTS LTD$15,655,000
+95.1%
128,000
+100.0%
0.28%
+52.2%
ATEC BuyALPHATEC HLDGS INC$15,320,000
+52.6%
1,000,000
+57.2%
0.27%
+18.6%
HBI NewHANESBRANDS INC$14,936,000800,000
+100.0%
0.27%
SIBN BuySI-BONE INC$14,350,000
+23.9%
456,000
+25.3%
0.26%
-3.4%
CROX NewCROCS INC$13,668,000117,300
+100.0%
0.24%
ADV BuyADVANTAGE SOLUTIONS INC$12,948,000
+21.8%
1,200,000
+33.3%
0.23%
-4.9%
MKC NewMCCORMICK & CO INC$12,012,000136,000
+100.0%
0.22%
TWTR NewTWITTER INC$10,322,000150,000
+100.0%
0.18%
DECK NewDECKERS OUTDOOR CORP$9,985,00026,000
+100.0%
0.18%
SIEN BuySIENTRA INC$9,552,000
+65.4%
1,200,000
+51.5%
0.17%
+28.6%
TRIP BuyTRIPADVISOR INC$9,027,000
+4.9%
224,000
+40.0%
0.16%
-18.2%
ACCO NewACCO BRANDS CORP$7,215,000836,000
+100.0%
0.13%
NOMD NewNOMAD FOODS LTD$5,654,000200,000
+100.0%
0.10%
DNAY NewCODEX DNA INC$4,400,000200,000
+100.0%
0.08%
TELA BuyTELA BIO INC$4,253,000
+14.2%
264,000
+5.6%
0.08%
-11.6%
AMYT BuyAMRYT PHARMA PLCsponsored ads$4,076,000
+46.3%
336,000
+68.0%
0.07%
+14.1%
RSLS NewRESHAPE LIFESCIENCES INC$4,083,000816,527
+100.0%
0.07%
RVPH NewREVIVA PHARMACEUTCLS HLDGS I$3,473,000714,700
+100.0%
0.06%
BCTX NewBRIACELL THERAPEUTICS CORP$3,040,000570,343
+100.0%
0.05%
STAF NewSTAFFING 360 SOLUTIONS INC$2,965,0005,162,720
+100.0%
0.05%
INM BuyINMED PHARMACEUTICALS INC$2,830,000
+264.7%
890,000
+278.7%
0.05%
+183.3%
DBGIW NewDIGITAL BRANDS GROUP INC*w exp 05/01/202$1,229,000722,890
+100.0%
0.02%
GMVDW NewG MED INNOVATIONS HLDGS LTD*w exp 06/30/202$1,035,0001,000,000
+100.0%
0.02%
SBEVWS NewSPLASH BEVERAGE GROUP INC*w exp 99/99/999$963,000875,000
+100.0%
0.02%
GROMW NewGROM SOCIAL ENTERPRISES INC*w exp 06/17/202$723,000723,000
+100.0%
0.01%
DTSTW NewDATA STORAGE CORP*w exp 05/13/202$18,00015,000
+100.0%
0.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings